title: Stoichiometry of N-methyl-D-aspartate receptors within the suprachiasmatic nucleus.
abstract: The circadian pacemaker within the suprachiasmatic nucleus (SCN) confers daily rhythms to bodily functions. In nature, the circadian clock will adopt a 24-h period by synchronizing to the solar light/dark cycle. This light entrainment process is mediated, in part, at glutamatergic synapses formed between retinal ganglion afferents and SCN neurons. N-methyl-D-aspartate receptors (NMDARs) located on SCN neurons gate light-induced phase resetting. Despite their importance in circadian physiology, little is known about their functional stoichiometry. We investigated the NR2-subunit composition with whole cell recordings of SCN neurons within the murine hypothalamic brain slice using a combination of subtype-selective NMDAR antagonists and voltage-clamp protocols. We found that extracellular magnesium ([Mg](o)) strongly blocks SCN NMDARs exhibiting affinities and voltage sensitivities associated with NR2A and NR2B subunits. These NMDAR currents were inhibited strongly by NR2B-selective antagonists, Ro 25-6981 (3.5 microM, 55.0 +/- 9.0% block; mean +/- SE) and ifenprodil (10 microM, 55.8 +/- 3.0% block). The current remaining showed decreased [Mg](o) affinities reminiscent of NR2C and NR2D subunits but was highly sensitive to [Zn](o), a potent NR2A blocker, showing a approximately 44.2 +/- 1.1% maximal inhibition at saturating concentrations with an IC(50) of 7.8 +/- 1.1 nM. Considering the selectivity, efficacy, and potency of the drugs used in combination with [Mg](o)-block characteristics of the NMDAR, our data show that both diheteromeric NR2B NMDARs and triheteromeric NR2A NMDARs (paired with an NR2C or NR2D subunits) account for the vast majority of the NMDAR current within the SCN.
authors.affiliation: Department of Neuroscience, University of Minnesota, 6-145 Jackson Hall, 321 Church St. SE, Minneapolis, MN 55455, USA.
authors.forename: J P
authors.initials: JP
authors.lastname: Clark
authors.forename: P
authors.initials: P
authors.lastname: Kofuji
mesh_terms: D000818:Animals; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D018408:Patch-Clamp Techniques / Q000379:methods; D010636:Phenols / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D021122:Protein Subunits / Q000378:metabolism; D016194:Receptors, N-Methyl-D-Aspartate / Q000737:chemistry / Q000378:metabolism*; D013493:Suprachiasmatic Nucleus / Q000166:cytology* / Q000378:metabolism
chemical_list: D018691:Excitatory Amino Acid Antagonists; D010636:Phenols; D010880:Piperidines; D021122:Protein Subunits; D016194:Receptors, N-Methyl-D-Aspartate; C109643:Ro 25-6981; D008274:Magnesium; C010739:ifenprodil
references.citation: Nature. 1984 Feb 2-8;307(5950):462-5
references.pmid: 6320006
references.citation: J Neurosci. 1994 Oct;14(10):6102-20
references.pmid: 7931566
references.citation: Neuron. 1999 May;23(1):171-80
references.pmid: 10402203
references.citation: Nature. 2002 Feb 14;415(6873):793-8
references.pmid: 11823786
references.citation: J Neurosci Res. 2000 Sep 15;61(6):663-73
references.pmid: 10972963
references.citation: Brain Res. 1999 Aug 7;837(1-2):106-16
references.pmid: 10433993
references.citation: Brain Res. 1988 Sep 20;460(2):297-313
references.pmid: 2465060
references.citation: J Pharmacol Exp Ther. 1997 Dec;283(3):1285-92
references.pmid: 9400004
references.citation: Brain Res. 1986 Jul 30;379(1):176-81
references.pmid: 3742212
references.citation: J Neurosci. 1999 Jun 15;19(12):5124-30
references.pmid: 10366645
references.citation: J Neuroendocrinol. 1999 Jan;11(1):43-51
references.pmid: 9918228
references.citation: J Neurosci. 2005 Jan 12;25(2):308-17
references.pmid: 15647474
references.citation: Neuroscience. 2003;119(1):137-44
references.pmid: 12763075
references.citation: J Gen Physiol. 1973 Jun;61(6):687-708
references.pmid: 4541078
references.citation: Mol Pharmacol. 1995 Nov;48(5):841-8
references.pmid: 7476914
references.citation: Neurosci Lett. 1994 Jul 18;176(1):59-62
references.pmid: 7970238
references.citation: J Neurosci. 1995 Oct;15(10):6509-20
references.pmid: 7472413
references.citation: J Pharmacol Exp Ther. 1997 Jul;282(1):326-38
references.pmid: 9223571
references.citation: J Neurosci. 2006 Oct 18;26(42):10899-910
references.pmid: 17050728
references.citation: Brain Res Mol Brain Res. 1994 Jun;23(4):338-44
references.pmid: 8090074
references.citation: Prog Neurobiol. 1996 Oct;50(2-3):109-32
references.pmid: 8971980
references.citation: Eur J Neurosci. 2006 Aug;24(4):1109-16
references.pmid: 16930436
references.citation: Neuroreport. 1996 Apr 26;7(6):1224-8
references.pmid: 8817537
references.citation: Neuroscience. 2009 Mar 17;159(2):599-609
references.pmid: 19361480
references.citation: BMC Neurosci. 2006 Feb 16;7:15
references.pmid: 16483357
references.citation: Cell Tissue Res. 2002 Jul;309(1):73-88
references.pmid: 12111538
references.citation: J Pharmacol Exp Ther. 2007 Aug;322(2):739-48
references.pmid: 17502428
references.citation: Neurosci Lett. 1995 Jan 30;184(3):181-4
references.pmid: 7715842
references.citation: Science. 2002 Feb 8;295(5557):1065-70
references.pmid: 11834834
references.citation: J Comp Neurol. 1993 Dec 15;338(3):377-90
references.pmid: 8113446
references.citation: Neuroscience. 2002;113(1):37-45
references.pmid: 12123682
references.citation: J Neurosci. 2005 Oct 5;25(40):9304-8
references.pmid: 16207890
references.citation: J Neurosci. 2001 Feb 15;21(4):1228-37
references.pmid: 11160393
references.citation: Science. 1992 Mar 20;255(5051):1581-4
references.pmid: 1549784
references.citation: J Physiol. 1999 Nov 15;521 Pt 1:99-111
references.pmid: 10562337
references.citation: Neuron. 2005 Apr 21;46(2):261-74
references.pmid: 15848804
references.citation: Brain Res. 1994 Apr 18;643(1-2):296-301
references.pmid: 8032923
references.citation: Eur J Neurosci. 2001 Apr;13(7):1420-8
references.pmid: 11298803
references.citation: J Neurosci. 2002 Jul 15;22(14):5955-65
references.pmid: 12122058
references.citation: Nat Neurosci. 1998 Dec;1(8):659-67
references.pmid: 10196581
references.citation: Mol Pharmacol. 1993 Oct;44(4):851-9
references.pmid: 7901753
references.citation: J Neurosci. 1997 Jan 15;17(2):667-75
references.pmid: 8987789
references.citation: Science. 1993 Apr 9;260(5105):238-41
references.pmid: 8097062
references.citation: J Neurosci Res. 2006 Nov 15;84(7):1512-20
references.pmid: 16983663
references.citation: Science. 2002 Feb 8;295(5557):1070-3
references.pmid: 11834835
references.citation: Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11062-7
references.pmid: 10984504
references.citation: J Physiol. 2001 Apr 1;532(Pt 1):181-94
references.pmid: 11283234
references.citation: Am J Physiol Regul Integr Comp Physiol. 2005 Sep;289(3):R656-62
references.pmid: 15860648
references.citation: J Neurosci. 1999 Aug 1;19(15):6637-42
references.pmid: 10414992
references.citation: J Neurophysiol. 2008 Jan;99(1):122-32
references.pmid: 18003876
references.citation: J Neurosci. 1997 Aug 1;17(15):5711-25
references.pmid: 9221770
references.citation: J Physiol. 1996 Dec 15;497 ( Pt 3):761-72
references.pmid: 9003561
references.citation: Nature. 1998 May 28;393(6683):377-81
references.pmid: 9620802
references.citation: J Biol Rhythms. 1992 Summer;7(2):125-36
references.pmid: 1611128
references.citation: J Biol Chem. 1993 Feb 5;268(4):2836-43
references.pmid: 8428958
references.citation: J Biol Chem. 2003 Jan 3;278(1):276-83
references.pmid: 12414797
references.citation: Curr Opin Neurobiol. 2001 Jun;11(3):336-42
references.pmid: 11399432
references.citation: Mol Pharmacol. 2002 Nov;62(5):1119-27
references.pmid: 12391275
references.citation: J Neurosci. 1995 Oct;15(10):6498-508
references.pmid: 7472412
references.citation: Mol Pharmacol. 2007 Oct;72(4):907-20
references.pmid: 17622578
references.citation: Eur J Neurosci. 2003 Jan;17(1):58-70
references.pmid: 12534969
references.citation: J Neurosci. 1996 Jun 1;16(11):3549-58
references.pmid: 8642401
references.citation: Neurosci Lett. 1996 Aug 30;215(1):9-12
references.pmid: 8880741
references.citation: J Neurophysiol. 2002 Apr;87(4):2052-63
references.pmid: 11929923
references.citation: Nat Neurosci. 2001 Sep;4(9):894-901
references.pmid: 11528420
references.citation: Brain Res Mol Brain Res. 1995 Feb;28(2):239-50
references.pmid: 7723623
references.citation: Sci STKE. 2004 Oct 19;2004(255):re16
references.pmid: 15494561
references.citation: Neuron. 1990 Aug;5(2):127-34
references.pmid: 2116813
references.citation: J Neurochem. 2001 Oct;79(1):161-71
references.pmid: 11595768
references.citation: Brain Res. 1997 May 30;758(1-2):245-9
references.pmid: 9203556
references.citation: Eur J Neurosci. 2008 Apr;27(7):1771-9
references.pmid: 18380671
references.citation: Neuron. 2000 Dec;28(3):911-25
references.pmid: 11163276
references.citation: Science. 1994 Dec 9;266(5191):1713-7
references.pmid: 7527589
references.citation: Nat Rev Neurosci. 2007 Oct;8(10):790-802
references.pmid: 17882255
references.citation: Brain Res. 1993 Dec 31;632(1-2):329-33
references.pmid: 8149240
references.citation: Am J Physiol. 1994 Aug;267(2 Pt 2):R360-4
references.pmid: 7520671
references.citation: Mol Pharmacol. 2000 Dec;58(6):1554-62
references.pmid: 11093796
references.citation: Nature. 1992 Jul 2;358(6381):36-41
references.pmid: 1377365
references.citation: Neurosci Lett. 1994 Jan 31;166(2):211-5
references.pmid: 8177501